Rare Cancer
-
Progress in Rare CancersWith the rise of patient-driven research and registries, scientists are making advances in understanding, diagnosing and treating many of the least common cancer types.
by Kendall K. Morgan
-
What Is Tumor Mutational Burden?The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
-
Survivor Profile
An Unlikely PivotMedha Deoras-Sutliff's experience with breast cancer fueled her interest in advocacy for breast cancer patients and, more recently, her support for research on rare cancers.
by Lindsey Konkel
-
Survivor Profile
Sharing Her StrengthDiagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.
by Lindsey Konkel
-
Advocacy in Action
Leaving a LegacyTwo mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
-
A Unified StrategyA couple who lost their daughter to brain cancer builds a charity that connects parents, hospitals and researchers with data.
by Marci A. Landsmann
-
Survivor Profile
Still in the GameESPN reporter Holly Rowe worked through melanoma treatment.
by Lindsey Konkel
-
More Options for Rare CancersPrecision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Learning to ShareAt first, I wanted to hide my cancer diagnosis. My son showed me what a mistake that was.
by Lenn Robbins
